The drug distributor will buy a majority stake in gastroenterology practice management group GI Alliance and purchase ...

The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...

McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

McKesson Corp. first bought an oncology group in 2010 ... The previous record was the $5.9 billion acquisition of Allegiance ...

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical ...

Oracle is reportedly in the running to acquire Veradigm, formerly Allscripts, according to a Nov. 10 report from Seeking Alpha.

Crypto stocks and TSLA. McKesson, Oracle among finalists to acquire Veradigm: report. Smith & Nephew investors may push for ...

It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...

We rate McKesson as a 'Strong Buy' with focus on GLP-1 meds, oncology network, and strong Q2 results driving future growth.

The classical understanding of personal autonomy, which still influences medical guidelines, is based on an individualistic framework and is inadequate for ethical mental health care. The goal of ...